A non-canonical glucose metabolic rewiring enables resistance to cancer targeted therapy
Hui-min Lei, Ruixue Xia, Yabin Tang, Jun Lu, Chan Xiang, Yujing Li, Hongyu Liu, Peichen Zou, Ayinazhaer Aihemaiti, Wei Zhang, Ying Shen, Baohui Han, Yuchen Han, Hua Zhong, Hongzhuan CHEN, Liang Zhu
The paper identifies a non-canonical glucose metabolic pathway involving GLUT6 that contributes to resistance to cancer targeted therapies in lung cancer.
Nature Communications · May 7, 2026Peer-reviewedCancer Biology